183 related articles for article (PubMed ID: 30221668)
1. Methylation status of KLF4 and HS3ST2 genes as predictors of endometrial cancer and hyperplastic endometrial lesions.
Danková Z; Braný D; Dvorská D; Ňachajová M; Fiolka R; Grendár M; Hatok J; Kubatka P; Holubeková V; Halašová E; Bielik T; Žúbor P
Int J Mol Med; 2018 Dec; 42(6):3318-3328. PubMed ID: 30221668
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation as a biomarker for the detection of hidden carcinoma in endometrial atypical hyperplasia.
Lai HC; Wang YC; Yu MH; Huang RL; Yuan CC; Chen KJ; Wu CC; Chiang KJ; Chao TK
Gynecol Oncol; 2014 Dec; 135(3):552-9. PubMed ID: 25449566
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
4. CpG Islands Methylation Analysis of CDH11, EphA5, and HS3ST2 Genes in Gastric Adenocarcinoma Patients.
Eyvazi S; Khamaneh AM; Tarhriz V; Bandehpour M; Hejazi MS; Sadat ATE; Sepehri B
J Gastrointest Cancer; 2020 Jun; 51(2):579-583. PubMed ID: 31407253
[TBL] [Abstract][Full Text] [Related]
5. Quantitative DNA methylation analysis of selected genes in endometrial carcinogenesis.
Chen YC; Tsao CM; Kuo CC; Yu MH; Lin YW; Yang CY; Li HJ; Yan MD; Wang TJ; Chou YC; Su HY
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):572-9. PubMed ID: 26522113
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.
Roperch JP; Grandchamp B; Desgrandchamps F; Mongiat-Artus P; Ravery V; Ouzaid I; Roupret M; Phe V; Ciofu C; Tubach F; Cussenot O; Incitti R
BMC Cancer; 2016 Sep; 16(1):704. PubMed ID: 27586786
[TBL] [Abstract][Full Text] [Related]
7. Analysis of DNA methylation in endometrial biopsies to predict risk of endometrial cancer.
Multinu F; Chen J; Madison JD; Torres M; Casarin J; Visscher D; Shridhar V; Bakkum-Gamez J; Sherman M; Wentzensen N; Mariani A; Walther-Antonio M
Gynecol Oncol; 2020 Mar; 156(3):682-688. PubMed ID: 31902687
[TBL] [Abstract][Full Text] [Related]
8. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
[TBL] [Abstract][Full Text] [Related]
9. Discovery and validation of methylation markers for endometrial cancer.
Wentzensen N; Bakkum-Gamez JN; Killian JK; Sampson J; Guido R; Glass A; Adams L; Luhn P; Brinton LA; Rush B; d'Ambrosio L; Gunja M; Yang HP; Garcia-Closas M; Lacey JV; Lissowska J; Podratz K; Meltzer P; Shridhar V; Sherman ME
Int J Cancer; 2014 Oct; 135(8):1860-8. PubMed ID: 24623538
[TBL] [Abstract][Full Text] [Related]
10. Identification of a non-coding KLF4 transcript generated from intron retention and downregulated in human hepatocellular carcinoma.
Zhou J; Lai PB; Tsui SK
Int J Oncol; 2015 Oct; 47(4):1554-62. PubMed ID: 26238073
[TBL] [Abstract][Full Text] [Related]
11. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma.
Arafa M; Kridelka F; Mathias V; Vanbellinghen JF; Renard I; Foidart JM; Boniver J; Delvenne P
Histopathology; 2008 Nov; 53(5):525-32. PubMed ID: 18783461
[TBL] [Abstract][Full Text] [Related]
12. Status and significance of CpG island methylator phenotype in endometrial cancer.
Zhang QY; Yi DQ; Zhou L; Zhang DH; Zhou TM
Gynecol Obstet Invest; 2011; 72(3):183-91. PubMed ID: 21968189
[TBL] [Abstract][Full Text] [Related]
13. Detection of clonality and genetic alterations in endometrial pipelle biopsy and its surgical specimen counterpart.
Esteller M; García A; Martínez-Palones JM; Xercavins J; Reventós J
Lab Invest; 1997 Jan; 76(1):109-16. PubMed ID: 9010454
[TBL] [Abstract][Full Text] [Related]
14. The analysis of methylation of DNA promoter of SFRP2 gene in patients with hyperplastic processes of the endometrium.
Marichereda VG; Bykovа NA; Bubnov VV; Manasova GS; Moskalenko TY; Volyanska AG; Shevchenko IM; Adamovska TM
Exp Oncol; 2018 Jun; 40(2):109-113. PubMed ID: 29949535
[TBL] [Abstract][Full Text] [Related]
15. Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.
Bakkum-Gamez JN; Wentzensen N; Maurer MJ; Hawthorne KM; Voss JS; Kroneman TN; Famuyide AO; Clayton AC; Halling KC; Kerr SE; Cliby WA; Dowdy SC; Kipp BR; Mariani A; Oberg AL; Podratz KC; Shridhar V; Sherman ME
Gynecol Oncol; 2015 Apr; 137(1):14-22. PubMed ID: 25677060
[TBL] [Abstract][Full Text] [Related]
16. Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers.
Zhang B; Xing X; Li J; Lowdon RF; Zhou Y; Lin N; Zhang B; Sundaram V; Chiappinelli KB; Hagemann IS; Mutch DG; Goodfellow PJ; Wang T
BMC Genomics; 2014 Oct; 15(1):868. PubMed ID: 25286960
[TBL] [Abstract][Full Text] [Related]
17. A Pyrosequencing Assay for the Quantitative Methylation Analysis of GALR1 in Endometrial Samples: Preliminary Results.
Kottaridi C; Koureas N; Margari N; Terzakis E; Bilirakis E; Pappas A; Chrelias C; Spathis A; Aga E; Pouliakis A; Panayiotides I; Karakitsos P
Biomed Res Int; 2015; 2015():756359. PubMed ID: 26504828
[TBL] [Abstract][Full Text] [Related]
18. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer.
Sasaki M; Dharia A; Oh BR; Tanaka Y; Fujimoto S; Dahiya R
Cancer Res; 2001 Jan; 61(1):97-102. PubMed ID: 11196205
[TBL] [Abstract][Full Text] [Related]
19. [Estimation of DNA methylation level in endometrial cancer tissues].
Popiela A; Gabryś MS; Rabczyński J; Pańszczyk M; Keith G; Baranowski W
Ginekol Pol; 2002 Nov; 73(11):966-9. PubMed ID: 12722383
[TBL] [Abstract][Full Text] [Related]
20. GALR1 methylation in vaginal swabs is highly accurate in identifying women with endometrial cancer.
Doufekas K; Hadwin R; Kandimalla R; Jones A; Mould T; Crowe S; Olaitan A; Macdonald N; Fiegl H; Wik E; Salvesen HB; Widschwendter M
Int J Gynecol Cancer; 2013 Jul; 23(6):1050-5. PubMed ID: 23727823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
